{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:01:16Z","timestamp":1763071276952,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022748","name":"Universidade Fernando Pessoa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100022748","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To compare 0.01% atropine with DIMS spectacle lenses in the prevention of myopia progression in European children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective study including data from pediatric European patients with myopia. From November 2021 to March 2022, only 0.01% atropine was prescribed because DIMS lenses were still not available in Portugal. From March to October 2022, only DIMS spectacle lenses were prescribed due to patients\u2019 parents\u2019 preference. Myopia progression endpoints were axial length (AL) and spherical equivalent (SE) differences between before and 6\u00a0months after treatment. AL and SE evolution were compared using a general linear model with repeated measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 98 eyes from 50 patients: 47 in the atropine group and 51 in the DIMS group. There were no statistically significant differences between groups in terms of initial AL, initial SE, sex or age. The mean AL elongation at 6\u00a0months was 0.057\u00a0mm in the atropine group (SD\u2009=\u20090.118) and 0.002\u00a0mm (SD\u2009=\u20090.077) in the DIMS group. SE progression was \u2212\u20090.098 (SD\u2009=\u20090.232) D in the atropine group and \u2212\u20090.039 (SD\u2009=\u20090.105) D in the DIMS group. AL elongation was significantly lower in the DIMS lens group (<jats:italic>p<\/jats:italic>\u2009=\u20090.038, partial Eta<jats:sup>2<\/jats:sup>\u2009=\u20090.045). There was no difference in SE progression between groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.302, partial Eta<jats:sup>2<\/jats:sup>\u2009=\u20090.011).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Comparison between 0.01% atropine eyedrops and DIMS spectacle lenses for slowing the progression of myopia favored DIMS lenses in terms of AL elongation in a short-term follow-up. There was no difference in terms of SE between groups.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10792-023-02788-x","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T17:01:56Z","timestamp":1688749316000},"page":"3777-3784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses\u2014a retrospective study in European children"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-641X","authenticated-orcid":false,"given":"Sandra","family":"Guimar\u00e3es","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-6641","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Barros da Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-8161","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Oliveiros","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-9854","authenticated-orcid":false,"given":"Eduardo","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"issue":"4","key":"2788_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10654-015-0010-0","volume":"30","author":"KM Williams","year":"2015","unstructured":"Williams KM, Verhoeven VJ, Cumberland P, Bertelsen G, Wolfram C, Buitendijk GH et al (2015) Prevalence of refractive error in Europe: the European eye epidemiology (E(3)) consortium. Eur J Epidemiol 30(4):305\u2013315. https:\/\/doi.org\/10.1007\/s10654-015-0010-0","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"2788_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P et al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123(5):1036\u20131042. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006","journal-title":"Ophthalmology"},{"issue":"2","key":"2788_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10237-019-01234-1","volume":"19","author":"JM Lakawicz","year":"2020","unstructured":"Lakawicz JM, Bottega WJ, Fine HF, Prenner JL (2020) On the mechanics of myopia and its influence on retinal detachment. Biomech Model Mechanobiol 19(2):603\u2013620. https:\/\/doi.org\/10.1007\/s10237-019-01234-1","journal-title":"Biomech Model Mechanobiol"},{"issue":"5","key":"2788_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.5.5","volume":"62","author":"K Ohno-Matsui","year":"2021","unstructured":"Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG et al (2021) IMI pathologic myopia. Investig Ophthalmol Vis Sci 62(5):5. https:\/\/doi.org\/10.1167\/iovs.62.5.5","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"2788_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1167\/iovs.61.4.49","volume":"61","author":"AEG Haarman","year":"2020","unstructured":"Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW (2020) The complications of myopia: a review and meta-analysis. Investig Ophthalmol Vis Sci 61(4):49. https:\/\/doi.org\/10.1167\/iovs.61.4.49","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"2788_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD et al (2021) IMI impact of myopia. Investig Ophthalmol Vis Sci 62(5):2. https:\/\/doi.org\/10.1167\/iovs.62.5.2","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2788_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.08.024","author":"J Dong","year":"2022","unstructured":"Dong J, Zhu Z, Xu H, He M (2022) Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind. Controll Clin Trial Ophthalmol. https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.024","journal-title":"Controll Clin Trial Ophthalmol"},{"issue":"8","key":"2788_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ophtha.2007.12.019","volume":"115","author":"KA Rose","year":"2008","unstructured":"Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W et al (2008) Outdoor activity reduces the prevalence of myopia in children. Ophthalmology 115(8):1279\u20131285. https:\/\/doi.org\/10.1016\/j.ophtha.2007.12.019","journal-title":"Ophthalmology"},{"key":"2788_CR9","doi-asserted-by":"publisher","first-page":"1004977","DOI":"10.1155\/2022\/1004977","volume":"2022","author":"A Russo","year":"2022","unstructured":"Russo A, Boldini A, Romano D, Mazza G, Bignotti S, Morescalchi F et al (2022) Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol 2022:1004977. https:\/\/doi.org\/10.1155\/2022\/1004977","journal-title":"J Ophthalmol"},{"key":"2788_CR10","unstructured":"Strabismus WSoPO. Myopia consensus statement 2023. 2023."},{"issue":"12","key":"2788_CR11","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"W-H Chua","year":"2006","unstructured":"Chua W-H, Balakrishnan V, Chan Y-H, Tong L, Ling Y, Quah B-L et al (2006) Atropine for the treatment of childhood myopia. Ophthalmology 113(12):2285\u20132291. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.062","journal-title":"Ophthalmology"},{"issue":"1","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.1999.15.85","volume":"15","author":"YF Shih","year":"1999","unstructured":"Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT (1999) Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 15(1):85\u201390. https:\/\/doi.org\/10.1089\/jop.1999.15.85","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"2788_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D (2016) Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology 123(2):391\u2013399. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.004","journal-title":"Ophthalmology"},{"issue":"3","key":"2788_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY-y, Lee RPK, Chun RKM, Hasegawa K et al (2020) Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol 104(3):363. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"2788_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bjophthalmol-2020-317664","volume":"106","author":"CSY Lam","year":"2022","unstructured":"Lam CSY, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K et al (2022) Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol 106(8):1110. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317664","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2788_CR16","first-page":"4247","volume":"63","author":"CS Lam","year":"2022","unstructured":"Lam CS, Tang WC, Zhang HY, Tse DY-y, To C-h (2022) Myopia control in children wearing DIMS spectacle lens: 6 years results. Investig Ophthalmol Vis Sci 63(7):4247","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"2788_CR17","doi-asserted-by":"publisher","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW (2023) A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS ONE 18(2):e0281816. https:\/\/doi.org\/10.1371\/journal.pone.0281816","journal-title":"PLoS ONE"},{"key":"2788_CR18","doi-asserted-by":"crossref","unstructured":"Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, et al.(2023) Interventions for myopia control in children: a living systematic review and network meta\u2010analysis. Cochrane Database Syst Rev. vol 2: Copyright \u00a9 2023 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration","DOI":"10.1002\/14651858.CD014758.pub2"},{"issue":"3","key":"2788_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/aos.13603","volume":"96","author":"JWL Tideman","year":"2018","unstructured":"Tideman JWL, Polling JR, Vingerling JR, Jaddoe VWV, Williams C, Guggenheim JA et al (2018) Axial length growth and the risk of developing myopia in European children. Acta Ophthalmol 96(3):301\u2013309. https:\/\/doi.org\/10.1111\/aos.13603","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"2788_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF et al (2022) Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology 129(3):308\u2013321. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.002","journal-title":"Ophthalmology"},{"key":"2788_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1125000","author":"C Lanca","year":"2023","unstructured":"Lanca C, Pang CP, Grzybowski A (2023) Effectiveness of myopia control interventions: a systematic review of 12 randomized control trials published between 2019 and 2021. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2023.1125000","journal-title":"Front Public Health"},{"issue":"12","key":"2788_CR22","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2017.05.030","volume":"124","author":"X Guo","year":"2017","unstructured":"Guo X, Fu M, Ding X, Morgan IG, Zeng Y, He M (2017) Significant axial elongation with minimal change in refraction in 3- to 6-year-old Chinese preschoolers: The Shenzhen Kindergarten eye study. Ophthalmology 124(12):1826\u20131838. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.030","journal-title":"Ophthalmology"},{"issue":"7","key":"2788_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.ophtha.2012.01.017","volume":"119","author":"F Xiang","year":"2012","unstructured":"Xiang F, He M, Morgan IG (2012) Annual changes in refractive errors and ocular components before and after the onset of myopia in Chinese children. Ophthalmology 119(7):1478\u20131484. https:\/\/doi.org\/10.1016\/j.ophtha.2012.01.017","journal-title":"Ophthalmology"},{"issue":"8","key":"2788_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/bjophthalmol-2020-318256","volume":"106","author":"D Tricard","year":"2022","unstructured":"Tricard D, Marillet S, Ingrand P, Bullimore MA, Bourne RRA, Leveziel N (2022) Progression of myopia in children and teenagers: a nationwide longitudinal study. Br J Ophthalmol 106(8):1104\u20131109. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318256","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"2788_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.62.10.36","volume":"62","author":"LA Jones-Jordan","year":"2021","unstructured":"Jones-Jordan LA, Sinnott LT, Chu RH, Cotter SA, Kleinstein RN, Manny RE et al (2021) Myopia progression as a function of sex, age, and ethnicity. Investig Ophthalmol Vis Sci 62(10):36. https:\/\/doi.org\/10.1167\/iovs.62.10.36","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"2788_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","volume":"139","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Musch DC, Wei N, Qi X, Ding G et al (2021) Progression of myopia in school-aged children after COVID-19 home confinement. JAMA Ophthalmol 139(3):293\u2013300. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.6239","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.62.5.3","volume":"62","author":"IG Morgan","year":"2021","unstructured":"Morgan IG, Wu PC, Ostrin LA, Tideman JWL, Yam JC, Lan W et al (2021) IMI risk factors for myopia. Investig Ophthalmol Vis Sci 62(5):3. https:\/\/doi.org\/10.1167\/iovs.62.5.3","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2788_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-320318","author":"TR Fricke","year":"2022","unstructured":"Fricke TR, Sankaridurg P, Naduvilath T, Resnikoff S, Tahhan N, He M et al (2022) Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-320318","journal-title":"Br J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02788-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T10:15:49Z","timestamp":1694772949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02788-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02788-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}